What researchers published on Neuromyelitis optica (NMOSD)
532 papers, newest first.
Showing 120 of 532
Not labelled yetDiscontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies.Neurology(R) neuroimmunology & neuroinflammation
Not labelled yetCortical Hierarchical Disorganization and Transcriptomic Associations in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders Revealed by Morphometric INverse Divergence Network Gradients.CNS neuroscience & therapeutics
Case reportDiagnostic dilemma in the management of a cervical spinal cord lesion: neuromyelitis optica spectrum disorder: a case report.Journal of medical case reports
Not labelled yetBiologic switching and relapses during biologic therapy in AQP4-IgG-positive NMOSD: a real-world study.Multiple sclerosis and related disorders
Case reportIntractable Nausea and Vomiting: A Key Feature of Neuromyelitis Optica Spectrum Disorder.The American journal of case reports
PreprintInnate Immune Dysregulation Precedes Clinical Onset in Neuromyelitis Optica.bioRxiv : the preprint server for biology
Not labelled yetPregnancy and Disease Activity in AQP4+ Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Multicenter Turkish Cohort.Noro psikiyatri arsivi
Case reportNeuromyelitis optica spectrum disorder presenting as rapidly progressive dementia: A case report.Medicine
ReviewRole of microglia in neuromyelitis optica (Review).International journal of molecular medicine
Not labelled yetA Case Report of Early Multimodal Immunotherapy for Rapidly Progressive Neuromyelitis Optica Spectrum Disorder with Extensive Brain Lesions.Internal medicine (Tokyo, Japan)
Not labelled yetPhenotypic and immunological profile divergence between SLE-associated myelitis and SLE-NMOSD overlap syndrome: a retrospective case series.Frontiers in immunology
Not labelled yetAssociation between psychosocial consequences of visual dysfunction and depressive symptom burden in multiple sclerosis and neuromyelitis optica spectrum disorder.Frontiers in neurology
Not labelled yetAQP4 antibody-induced astrocyte injury reshapes CNS immune architecture in a combined EAE-AQP4-IgG model of neuromyelitis optica spectrum disorder.Frontiers in immunology
Not labelled yetProportion and Clinical Characteristics of Double-Seronegative NMOSD in a Multicenter Real-World Cohort.European journal of neurology
Case reportCerebral Air Embolism After Double-lumen Catheter Removal for Plasmapheresis: A Case Report.Acta neurologica Taiwanica
Not labelled yetPhase-associated differences in perivascular and glymphatic-related MRI markers in AQP4-IgG-seropositive neuromyelitis Optica spectrum disorder: A cross-sectional study.Multiple sclerosis and related disorders
ReviewLatin American consensus recommendations on the role of magnetic resonance imaging in neuromyelitis optica spectrum disorder in clinical practice.Multiple sclerosis and related disorders
Not labelled yetCharacteristics of serum Metrnl levels in patients with neuromyelitis optica spectrum disorder and their associations with disease activity and inflammatory biomarkers.Frontiers in immunology
Not labelled yetEfficacy of Fampridine on Refractory Optic Neuritis in Neuromyelitis Optica Spectrum Disorders.Annals of clinical and translational neurology
Not labelled yetEfficacy and Safety of Multidisciplinary Sandwich Regimen in AQP4-IgG+ NMOSD With Preconception B-Cell Depletion During Perigravidity.CNS neuroscience & therapeutics
Not labelled yetIsolated Extramedullary Trigeminal Nerve Root Lesion in Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 Immunoglobulin G.The Neurohospitalist
Not labelled yetAltered intersubject variability of functional connectivity in gray and white matter underlying neurocognition and genetic profiles in neuromyelitis optica spectrum disorder.Neural regeneration research
ReviewThe Balance Between Immune Activation and Tolerance in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorders and MOG Antibody-Associated Disease.Immunology and cell biology
Observational studyRavulizumab in neuromyelitis optica spectrum disorder: first clinical experience in Chile.Frontiers in immunology
Not labelled yetInvestigation of Complement Activation and Cytokine Signatures in AQP4+ NMOSD, MOGAD, and MS.Annals of clinical and translational neurology
Not labelled yetSoluble TIM-3 and galectin-9 in cerebrospinal fluid are associated with disability at 6 months in aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder.Frontiers in immunology
Not labelled yetProgressive hemifacial atrophy, AQP4-positive NMOSD and suspected Sjögren's syndrome: five-year relapse-free follow-up during rituximab therapy.Acta neurologica Belgica
Not labelled yetDifferential Trajectories of Brain Atrophy in Multiple Sclerosis, MOGAD, and AQP4 + NMOSD: The Role of Disease Activity in MOGAD.Neurology
Not labelled yetCharacterization of distinct cognitive domain patterns in AQP4-IgG-positive NMOSD: A MoCA-based factor analysis and risk profiling.Multiple sclerosis and related disorders
Not labelled yetIncreased autoimmune disease burden before multiple sclerosis and neuromyelitis optica spectrum disorder diagnosis: A nationwide Korean cohort study.Multiple sclerosis (Houndmills, Basingstoke, England)
ReviewRecognizing and Differentiating Area Postrema Syndrome Across NMOSD, MOGAD, and GFAP Astrocytopathy.International journal of molecular sciences
Not labelled yetCo-occurrence of myasthenia gravis and neuromyelitis optica spectrum disorder: A case series and literature review.Journal of neuroimmunology
Not labelled yetNOP58 knockdown in microglia is associated with reduced neuroinflammation and synaptic damage in NMOSD.Journal of neuroimmunology
Not labelled yetClinical phenotype and treatment response in AQP4-IgG-positive NMOSD and MOGAD: insights from the Italian I-MS&RD registry.Journal of neurology
Not labelled yetUtility of Blood Neutrophil to Diagnose Bacterial Infections under Satralizumab Treatment for Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Report of Two Cases.Internal medicine (Tokyo, Japan)
ReviewWhy repair fails in AQP4-IgG-positive neuromyelitis optica spectrum disease: an astrocyte-centered framework for remyelination and neuroaxonal preservation.Frontiers in immunology
Not labelled yetNutritional Status in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.Journal of clinical medicine research
Not labelled yetBeyond physical disability: the case for systematic mental health screening in the care of NMOSD and MOGAD in Latin America.Multiple sclerosis and related disorders
Not labelled yetCerebral Attack With Cortical-Leptomeningeal Involvement and Seizures in AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.Internal medicine (Tokyo, Japan)
Not labelled yetCase Report: Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder: Diagnostic Challenges and Transition From B-Cell Depletion Therapy to Ravulizumab.Clinical case reports
Not labelled yetBlood Glial Fibrillary Acidic Protein in MRI-Negative Attack-Like Episodes of Neuromyelitis Optica Spectrum Disorder.European journal of neurology
Not labelled yetNursing Protocols and Observed Outcomes of TR-350 Immunoadsorption in Neuromyelitis Optica Spectrum Disorder: A Single-Center Experience of 334 Procedures.Blood purification
Not labelled yetLong-term neuropsychiatric outcomes in offspring of mothers with multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study.Multiple sclerosis and related disorders
Case reportCase Report: Unplanned pregnancy during treatment with inebilizumab in patients with AQP4-IgG-seropositive NMOSD: report of two cases.Frontiers in immunology
Not labelled yetHow patients with neuromyelitis optica spectrum disease accumulate disability.Multiple sclerosis (Houndmills, Basingstoke, England)
Not labelled yetNeuromyelitis optica spectrum disorder associated with Kabuki syndrome: First reported case and immunopathogenic considerations.Multiple sclerosis (Houndmills, Basingstoke, England)
Randomised trialAstrocytic and Axonal Injury Biomarkers in AQP4 Antibody-Positive NMOSD: Insights From PREVENT and CHAMPION-NMOSD.Neurology(R) neuroimmunology & neuroinflammation
In plain wordsRead moreRead the paper on PubMedNot labelled yetTeaching NeuroImage: Neuromyelitis Optica Spectrum Disease Presenting as a Tumefactive Thalamic Lesion.Neurology
Not labelled yetTargeting C3aR/STAT3 signaling attenuates neuroinflammation and reverses neurological impairment in Neuromyelitis optica.Fundamental research
Meta-analysisPrevalence of autoimmune comorbidities in aquaporin 4-immunoglobulin G positive neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.Multiple sclerosis and related disorders
In plain wordsRead moreRead the paper on PubMedNot labelled yetTop-Down CSF Peptidomics Reveals Disease-Associated Peptide Signatures and Oxidative Modifications in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.Proteomics
Case reportNeuromyelitis optica spectrum disorder with positive anti-aquaporin-4 antibodies in the context of long-standing rheumatoid arthritis: A case report.Reumatologia clinica
Not labelled yetDisease-specific patterns of glymphatic-related dysfunction between multiple sclerosis and neuromyelitis optica spectrum disorder.Frontiers in immunology
Not labelled yetComplement C5 inhibitor as a rescue therapy for acute NMOSD attacks: a multicenter retrospective cohort study in China.Frontiers in immunology
ReviewEculizumab and Ravulizumab During Pregnancy in Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis: Balancing Maternal Disease Control and Fetal Safety.CNS drugs
ReviewOptimizing the management of AQP4 antibody-positive NMOSD: A Canadian consensus.Multiple sclerosis and related disorders
ReviewMetabolic reprogramming in neuromyelitis optica spectrum disorder: From astrocyte dysfunction to immune-mediated neuroinflammation.Multiple sclerosis and related disorders
Not labelled yetDiagnostic delay and poor functional outcomes in late-onset NMOSD: A Thai cohort study.Multiple sclerosis and related disorders
Not labelled yetCorrection to "Neuromyelitis Optica Mimicking Multiple Sclerosis: A Case Report and a Comprehensive Review of the Literature".Clinical case reports
Case reportCase Report: Confirmed and suspected heparin-induced thrombocytopenia during therapeutic plasma exchange in neuromyelitis optica spectrum disorder: a single-centre case series.Frontiers in immunology
ReviewUse of MRI in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease - MAGNIMS consensus recommendations.Nature reviews. Neurology
Not labelled yetSerum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack.European journal of neurology
Not labelled yetMeningococcal infection in patients receiving eculizumab or ravulizumab for generalized myasthenia gravis or neuromyelitis optica spectrum disorder: A real-world study of US clinical practice.Journal of the neurological sciences
Not labelled yetAFRICTRIMS: Should exclusion of NMOSD/MOGAD be a prerequisite for initiating MS disease-modifying therapy? - Commentary.Multiple sclerosis (Houndmills, Basingstoke, England)
Not labelled yetAFRICTRIMS: Should exclusion of NMOSD/MOGAD be a prerequisite for initiating MS disease-modifying therapy? Yes.Multiple sclerosis (Houndmills, Basingstoke, England)
Not labelled yetAFRICTRIMS: Should exclusion of neuromyelitis optica spectrum disorder/myelin oligodendrocyte glycoprotein antibody-associated disease be a prerequisite for initiating MS disease-modifying therapy? - No.Multiple sclerosis (Houndmills, Basingstoke, England)
Not labelled yetDiagnostic Utility of Novel and Established Spinal MRI Signs in AQP4-IgG-Seropositive NMOSD Myelitis.Neurology
Not labelled yetFrom Lesion Length to Lesion Pattern in Neuromyelitis Optica Spectrum Disorder Myelitis: Implications for Diagnostic Criteria.Neurology
Not labelled yetPotential links between gut microbiota-derived propionate and succinate and CXCL8, IL1B, and IL6 in NMOSD: An integrated network pharmacology and mendelian randomization study.Journal of neuroimmunology
Not labelled yetElevated ISG15 reinforces RIG-I/MDA5-linked macrophage-microglia crosstalk during blood-brain barrier disruption in neuromyelitis optica spectrum disorder.International immunopharmacology
Not labelled yetOpsoclonus-Myoclonus-Ataxia Revealing Underlying Neuromyelitis Optica Spectrum Disorder.Movement disorders clinical practice
Not labelled yetComparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.Journal of neurology, neurosurgery, and psychiatry
Not labelled yetComparison of iron and myelin changes in U‑fiber regions of relapsing-remitting multiple sclerosis and neuromyelitis optica spectrum disorders.Journal of neurology
Not labelled yetFunctional and effective connectivity alterations relate to cognitive performance in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.Brain communications
ReviewRecognition and management of acute relapse of multiple sclerosis, neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.Cell death and differentiation
Not labelled yetDeeper versus broader B cell depletion in neuromyelitis optica spectrum disorder.Nature reviews. Neurology
Not labelled yetClinicopathological features of double-seronegative NMOSD with tumefactive demyelination.Multiple sclerosis and related disorders
Not labelled yetmiRNA-34b overexpression alleviates neuromyelitis optica spectrum disorders by regulating the TIA-1-stress granule pathway.Pakistan journal of pharmaceutical sciences
Not labelled yetCorrigendum to "Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic study" [Multiple Sclerosis and Related Disorders, Volume 97 (2025): 106383].Multiple sclerosis and related disorders
Not labelled yetMultimodal assessment of sleep and regional brain volumes in AQP4-IgG-positive neuromyelitis optica spectrum disorder: An exploratory cross-sectional study.Multiple sclerosis and related disorders
Meta-analysisA systematic review and meta-analysis of the efficacy and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.Multiple sclerosis and related disorders
In plain wordsRead moreRead the paper on PubMedNot labelled yetPatient education for neuromyelitis optica spectrum disorder using large language models: combining expert assessment and real-world patient interaction.Frontiers in physiology
Not labelled yetPrimary Central Nervous System Histiocytic Sarcoma During Neuromyelitis Optica Spectrum Disorder.Journal of clinical neurology (Seoul, Korea)
ReviewMultimodal MRI biomarkers and machine learning in neuromyelitis optica spectrum disorder: a review.Frontiers in neurology
Case reportMovement-Provoked Paroxysmal Neuralgia Following Longitudinally Extensive Transverse Myelitis in Neuromyelitis Optica Spectrum Disorder: A Presumed Ephaptic Spinal Cord Phenomenon.Cureus
ReviewNeuromyelitis optica spectrum disorder overlapping with Sjögren's disease: immunopathological links and therapeutic implications.Frontiers in immunology
Not labelled yetReduced FOXP3 expression and its association with genetic ancestry in neuromyelitis Optica spectrum disorder: a Colombian cohort.Multiple sclerosis and related disorders
ReviewGlobal trends and emerging hotspots in neuromyelitis optica spectrum disorder diagnostic research: A bibliometric analysis.Medicine
Not labelled yetAging of the Patients with Neuromyelitis Optica Spectrum Disorder in the Noto Peninsula, Japan.European neurology
Case reportEarly Inpatient Rehabilitation Following Neuromyelitis Optica Spectrum Disorder Flare: A Case Report.Cureus
Not labelled yetNeuromyelitis optica spectrum disorder patients dyadic coping patterns: a latent profile analysis.Frontiers in psychology
Not labelled yetAltered Blood-Brain Barrier Water Exchange in Remission-Phase Neuromyelitis Optica Spectrum Disorder: A WEPCAST MRI Study.European journal of radiology
Not labelled yetSafety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan.Neurology and therapy
Not labelled yetSerum SERPINA3 as a Candidate Non-Invasive Biomarker for Neuromyelitis Optica Spectrum Disorder: Proteomic Discovery and Same-Center Validation.Diagnostics (Basel, Switzerland)
Not labelled yetThe Comprehensive Live Cell-Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD.Annals of clinical and translational neurology
Guideline[Recommendations for the diagnosis and treatment of optic neuromyelitis in children and adolescents].Medicina
ReviewDe-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.Neurology
Not labelled yetAntibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models.Science translational medicine
ReviewNMOSD and MOGAD in Latin America: A consensus-informed regional perspective.Multiple sclerosis and related disorders
Not labelled yetInebilizumab in AQP4-Seropositive NMOSD: One-Year Follow-Up From a Multicenter, Real-World Study.Annals of clinical and translational neurology
Case reportPediatric Post-COVID-19 Neuromyelitis Optica Spectrum Disorder: A Case Report.Cureus
Not labelled yetAge-stratified clinical characteristics and disability outcomes in neuromyelitis optica spectrum disorder: A cross-sectional study.Acta neurologica Belgica
Not labelled yetTherapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorder: Real-World Clinical Outcomes and Safety From a Tertiary Care Center in Northwest India.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
ReviewOCTA-derived retinal microvascular biomarkers in neuromyelitis optica spectrum disorder: clinical potential, methodological challenges, and possible links to astrocytopathy.Frontiers in medicine
ReviewIntractable hiccups as a brainstem red flag: demyelinating disorders with emphasis on neuromyelitis optica spectrum disorder and area postrema syndrome.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Not labelled yetPrevalence of neuromyelitis optica spectrum disorder in Fujian, China, 2021-2023: a population-based study.Neuroepidemiology
Case reportCase Report: Pharmacological decision-making in pregnant women with neuromyelitis optica spectrum disorder: two contrasting clinical scenarios.Frontiers in pharmacology
Not labelled yetClinical and serological features of systemic autoimmune overlap in AQP4-IgG positive neuromyelitis optica spectrum disorder: a Mexican cohort study.Multiple sclerosis and related disorders
ReviewUse of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications.Neurology(R) neuroimmunology & neuroinflammation
Randomised trialObinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.Nature medicine
In plain wordsRead moreRead the paper on PubMedNot labelled yetComplement C3 inhibitory peptide AMY-101 ameliorates brain injury in a mouse model of NMOSD.Annals of medicine
Not labelled yetData-augmented machine learning refines the effective-concentration estimate for eculizumab in complement-mediated diseases.Frontiers in immunology
Case reportNeuromyelitis optica presenting with mammillary body and cervicomedullary lesions after severe hyponatremia mimicking osmotic demyelination syndrome.Radiology case reports
Not labelled yetRoles of cerebrospinal fluid metabolites in neuromyelitis optica spectrum disorder: Insights from Mendelian randomization.Medicine
Case reportCoexistence of Neuromyelitis Optica Spectrum Disorder and Proliferative Lupus Nephritis: A Rare Case Report.The Journal of the Association of Physicians of India
Case reportExpanding the Spectrum: Isolated Acute Diencephalitis as the Initial Manifestation of Neuromyelitis Optica Spectrum Disorder.The Journal of the Association of Physicians of India
Not labelled yetRavulizumab rescue therapy in a refractory AQP4-positive neuromyelitis optica attack with extensive encephalomyelitis.Revue neurologique
Not labelled yetA Multidisciplinary Neuropsychology-Neuroimmunology Clinic Model for Pediatric Neuroimmune Disorders.Pediatric neurology
Not labelled yetUpdate on the Incidence of Paediatric Multiple Sclerosis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Other Acquired Demyelinating Syndromes in the Netherlands, 2017-2025, Including the COVID-19 Pandemic.European journal of neurology
Not labelled yetHigh early mortality and contributing factors in seropositive neuromyelitis optica spectrum disorder at a tertiary hospital in Zambia.Multiple sclerosis and related disorders